Metabolon's Precision Metabolomics
technology screens a metabolite library, using proprietary software to deliver metabolomics
New range of enhanced technologies for accuracy and precision in metabolomics
research and growth in emerging markets due to increasing investments presents significant growth opportunities for players in the market.
market report estimates the market size (Revenue USD million - 2013 to 2020) and key market segments based on detection and separation techniques used, its applications (biomarker discovery, clinical toxicology, drug assessment, and nutrigenomics), and forecasts growth trends (CAGR% - 2016 to 2020).
In the quest for identification of a suitable biomarker for breast cancer, novel and high-yield technologies like genomics, proteomics, and metabolomics
have received a lot of attention in recent times, prompting the researchers to name this as the era of "Breast cancer OMICS".
With respect to the validation of new laboratory diagnostics, all (pre)diabetes metabolomics
markers or patterns detected to date have been carefully evaluated.
Products that Waters sells for metabolomics
applications include the Q-Tof Premier Q-TOF MS system, the Waters Metabonomics UPLC/MS/MS system, and Metabolynx, a software package that interprets MS data.
study of diabetic and non-diabetic patients
To meet this challenge, the marriage of transcriptomics, proteomics, metabolomics
, and bioinformatics with toxicology in the emerging field of toxicogenomics allows the study of hundreds or even thousands of molecular targets simultaneously.
" (metabolites represent the end products of genetic expression and the analysis of large numbers of metabolites has been termed metabolomics
) publishes research in the areas of: the development of various technology platforms for metabolomics
, profiling and fingerprinting; improvements in data preparation, storage and analyses; comparative studies within a systems biology context; and, the application of metabolomics
in all organisms.
Research Triangle Park, NC), a leader in the application of metabolomics
to design novel therapies, formed a collaboration with the High Q Foundation on a new biomarker study for Huntington's Disease (HD).
Contract notice: the acquisition of an automated system for the preparation of high-throughput samples for metabolomics